About
Shaharyar Khan, Ph.D. is a biotech scientist and company builder focused on mitochondrial biology and cardiometabolic therapeutics. He is co-founder, Chief Scientific Officer, and a director of Rivus Pharmaceuticals, where he leads scientific strategy around mitochondrial-targeted drug development. Before Rivus, he co-founded Gencia Biotech and served as its Chief Scientific Officer.
Areas of interest
biotechmitochondrial biologymitochondrial therapeuticscardiometabolic healthobesityMASHdrug discoveryneuroscience